Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

We evaluated quality of life (QL) and quality-adjusted survival in International Breast Cancer Study Group Trial IX, a randomised trial including 1669 eligible patients receiving tamoxifen for 5 years or three prior cycles of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) followed by 57 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernhard, J, Zahrieh, D, Coates, A S, Gelber, R D, Castiglione-Gertsch, M, Murray, E, Forbes, J F, Perey, L, Collins, J, Snyder, R, Rudenstam, C-M, Crivellari, D, Veronesi, A, Thürlimann, B, Fey, M F, Price, K N, Goldhirsch, A, Hürny, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409769/
https://www.ncbi.nlm.nih.gov/pubmed/15545973
http://dx.doi.org/10.1038/sj.bjc.6602230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409769/
https://www.ncbi.nlm.nih.gov/pubmed/15545973
http://dx.doi.org/10.1038/sj.bjc.6602230

Ejemplares similares